• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD.

作者信息

Cannatelli Rosanna, Ferretti Francesca, Carmagnola Stefania, Bergna Irene Maria Bambina, Monico Maria Camilla, Maconi Giovanni, Ardizzone Sandro

机构信息

Gastroenterology and Digestive Endoscopy Unit, Department of Biochemical and Clinical Sciences 'L Sacco', University of Milan, ASST Fatebenefratelli Sacco, Milano, Italy

Gastroenterology and Digestive Endoscopy Unit, Department of Biochemical and Clinical Sciences 'L Sacco', University of Milan, ASST Fatebenefratelli Sacco, Milano, Italy.

出版信息

Gut. 2022 Sep;71(9):1926-1928. doi: 10.1136/gutjnl-2021-326237. Epub 2021 Nov 24.

DOI:10.1136/gutjnl-2021-326237
PMID:34819330
Abstract
摘要

相似文献

1
Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD.炎症性肠病患者接种新冠疫苗后出现不良事件及报告的临床复发风险。
Gut. 2022 Sep;71(9):1926-1928. doi: 10.1136/gutjnl-2021-326237. Epub 2021 Nov 24.
2
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.抗 SARS-CoV-2 疫苗在炎症性肠病患者中的实施情况和短期不良事件：一项国际网络调查。
J Crohns Colitis. 2022 Aug 4;16(7):1070-1078. doi: 10.1093/ecco-jcc/jjac010.
3
Safety of COVID-19 Vaccination in Inflammatory Bowel Disease Patients on Biologic Therapy.接受生物治疗的炎症性肠病患者接种新冠疫苗的安全性
J Crohns Colitis. 2022 May 10;16(4):687-688. doi: 10.1093/ecco-jcc/jjab189.
4
SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.SARS-CoV-2 疫苗接种在炎症性肠病中的应用：过去的经验教训、当前的证据和未来的挑战。
J Crohns Colitis. 2021 Aug 2;15(8):1376-1386. doi: 10.1093/ecco-jcc/jjab046.
5
[SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].[成人炎症性肠病患者的新型冠状病毒2型疫苗接种：韩国炎症性肠病学会专家共识声明]
Korean J Gastroenterol. 2021 Aug 25;78(2):117-128. doi: 10.4166/kjg.2021.110.
6
Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review.比较 COVID-19 疫苗接种在炎症性肠病（IBD）患者中的效果和副作用：系统范围综述。
BMC Gastroenterol. 2022 Aug 20;22(1):393. doi: 10.1186/s12876-022-02460-1.
7
COVID-19 Vaccines in IBD Patients: Particularities and Future Perspectives.炎症性肠病患者的新冠疫苗：特殊性与未来展望
J Crohns Colitis. 2022 Sep 8;16(9):1343-1344. doi: 10.1093/ecco-jcc/jjac042.
8
Attitudes towards COVID-19 vaccination in patients with inflammatory bowel disease.炎症性肠病患者对 COVID-19 疫苗接种的态度。
Intern Med J. 2022 Jun;52(6):1070-1074. doi: 10.1111/imj.15722. Epub 2022 May 18.
9
Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.寒冬将至！2019冠状病毒病大流行期间炎症性肠病患者疫苗接种的临床、免疫学及实际考量
Gastroenterology. 2021 Feb;160(3):639-644. doi: 10.1053/j.gastro.2020.10.013. Epub 2020 Oct 14.
10
Effects of COVID-19 on Patients with Inflammatory Bowel Disease.COVID-19 对炎症性肠病患者的影响。
R I Med J (2013). 2022 Dec 1;105(10):42-47.

引用本文的文献

1
Causal relationship between COVID-19, vaccination, and 20 digestive diseases: a comprehensive two-sample Mendelian randomization study.2019冠状病毒病、疫苗接种与20种消化系统疾病之间的因果关系：一项全面的两样本孟德尔随机化研究
Virol J. 2025 Jun 30;22(1):213. doi: 10.1186/s12985-025-02847-y.
2
SARS-CoV-2 Infection, Vaccination, and Irritable Bowel Syndrome in Veterans: A Cross-Sectional Study.退伍军人中的新型冠状病毒2型感染、疫苗接种与肠易激综合征：一项横断面研究
Int J Gasteroenterol (N Y). 2024 Dec;8(2):76-84. doi: 10.11648/j.ijg.20240802.14. Epub 2024 Nov 29.
3
SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study.
炎症性肠病患者接种 SARS-CoV-2 疫苗与疾病活动无关：一项瑞士单中心回顾性研究。
Ann Med. 2024 Dec;56(1):2295979. doi: 10.1080/07853890.2023.2295979. Epub 2024 Jan 30.
4
Disease Flares Following COVID-19 Vaccination in Patients with Inflammatory Bowel Disease.炎症性肠病患者接种 COVID-19 疫苗后的疾病发作。
Intern Med. 2023 Dec 15;62(24):3579-3584. doi: 10.2169/internalmedicine.2335-23. Epub 2023 Sep 29.
5
Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study.接种 SARS-CoV-2 mRNA 疫苗后炎症性肠病患者的疫苗接种后症状：一项前瞻性、对照研究。
Inflamm Bowel Dis. 2024 Apr 3;30(4):602-616. doi: 10.1093/ibd/izad114.
6
Investigating the association between the COVID-19 vaccination and incident gastrointestinal symptomology: A comprehensive dataset.调查新冠病毒疫苗接种与新发胃肠道症状之间的关联：一个综合数据集。
Data Brief. 2023 Jun;48:109287. doi: 10.1016/j.dib.2023.109287. Epub 2023 Jun 1.
7
Postvaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease.BNT162b2 疫苗接种后对儿童炎症性肠病患者的 SARS-CoV-2 免疫原性及其预测因素
J Pediatr Gastroenterol Nutr. 2023 Feb 1;76(2):e36-e44. doi: 10.1097/MPG.0000000000003661. Epub 2022 Nov 23.
8
Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-Term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study.BNT162b2 mRNA疫苗接种对炎症性肠病短期和长期疫苗相关不良事件发生情况的影响：一项多中心前瞻性研究
Front Med (Lausanne). 2022 Jun 8;9:881027. doi: 10.3389/fmed.2022.881027. eCollection 2022.
9
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis.新型冠状病毒疫苗在炎症性肠病患者中的安全性：系统评价和荟萃分析。
Dig Liver Dis. 2022 Jun;54(6):713-721. doi: 10.1016/j.dld.2022.03.005. Epub 2022 Mar 22.
10
Effectiveness and safety of SARS-CoV-2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta-analysis and meta-regression.新型冠状病毒疫苗在炎症性肠病患者中的有效性和安全性：系统评价、荟萃分析和荟萃回归。
Aliment Pharmacol Ther. 2022 May;55(10):1244-1264. doi: 10.1111/apt.16913. Epub 2022 Mar 30.